RT Journal Article
SR Electronic
T1 Role of Insulin and Atrial Natriuretic Peptide in Sodium Retention in Insulin-Treated IDDM Patients During Isotonic Volume Expansion
JF Diabetes
JO Diabetes
FD American Diabetes Association
SP 289
OP 298
DO 10.2337/diab.39.3.289
VO 39
IS 3
A1 Trevisan, Roberto
A1 Fioretto, Paola
A1 Semplicini, Andrea
A1 Opocher, Giuseppe
A1 Mantero, Franco
A1 Rocco, Stefano
A1 Remuzzi, Giuseppe
A1 Morocutti, Anna
A1 Zanette, Giorgio
A1 Donadon, Valter
A1 Perico, Norberto
A1 Giorato, Cinzia
A1 Nosadini, Romano
YR 1990
UL http://diabetes.diabetesjournals.org/content/39/3/289.abstract
AB Because insulin shows an antinatriuretic effect in healthy humans, insulin therapy resulting in circulating hyperinsulinemia may lead to sodium retention and in turn to hypertension in individuals with insulin-dependent diabetes mellitus (IDDM). Moreover, it has been proved that atrial natriuretic peptide (ANP) plays a major role in modulating natriuresis in humans. This study investigated the relationship between insulin and ANP in modulating sodium metabolism in normotensive and hypertensive IDDM subjects compared with control groups of normotensive and hypertensive nondiabetic subjects. IDDM normotensive and hypertensive subjects had mean ± SE duration of IDDM of 7 ± 2 and 8 ± 2 yr, respectively, and had no clinical features of diabetic nephropathy. All subjects received a saline infusion (2 mmol · kg−1 · 90 min−1) during euglycemia. IDDM normotensive and hypertensive subjects received a subcutaneous insulin infusion (15 mU · kg−1 · h−1), resulting in twofold higher plasma free-insulin levels (16 ± 2 and 19 ± 3 μU/ml, respectively) than in nondiabetic normotensive and hypertensive subjects (7 ± 2 and 8 ± 2 μU/ml, respectively). During saline challenge, sodium excretion increased by 22 ± 4% in normotensive and 49 ± 9% in hypertensive nondiabetic subjects but by only 11 ± 0.4% in normotensive (P < 0.01) and 8 ± 2% in hypertensive (P < 0.01) IDDM subjects. The impaired natriuretic response to saline challenge was mainly due to greater rates of sodium reabsorption by kidney proximal tubules in IDDM than nondiabetic subjects. At baseline, plasma ANP concentrations were significantly higher in both IDDM groups than in control groups (normotensive IDDM and control subjects: 38 ± 4 and 19 ± 2 pg/ml, respectively, P < 0.01 ; hypertensive IDDM and control subjects: 45 ± 6 and 27 ± 4 pg/ml, respectively, P < 0.05). After saline challenge, ANP concentrations rose to 39 ± 4 pg/ml in normotensive and 49 ± 5 pg/ml in hypertensive control subjects, whereas no significant change above baseline value was seen in IDDM subjects. Both IDDM groups showed a 10–12% greater exchangeable Na+pool than control subjects regardless of the presence of hypertension. Subcutaneous insulin infusion, resulting in circulating plasma free-insulin levels in normotensive control subjects comparable to those in IDDM patients, inhibited natriuresis, increased proximal tubule sodium reabsorption at the level of the kidney, and inhibited an adequate ANP stimulation by saline challenge. We conclude that hyperinsulinemia leads to increased proximal tubule sodium reabsorption and impaired ANP response during saline administration. Both mechanisms account for sodium retention in normotensive and hypertensive IDDM patients. Sodium retention seems to characterize insulin-treated diabetes regardless of the presence of hypertension, suggesting that insulin-induced expansion of the Na+ pool alone cannot produce hypertension and requires the concomitant interaction of other pathogenetic factors.